Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy
Author:
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2133.2011.10658.x/fullpdf
Reference31 articles.
1. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins;Ishii;J Immunol,1997
2. The adjuvant therapy of pemphigus. An update;Bystryn;Arch Dermatol,1996
3. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases;Ahmed;Arch Dermatol,2003
4. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin;Ahmed;N Engl J Med,2006
5. Relevance of rituximab therapy in pemphigus vulgaris: analysis of current data and the immunologic basis for its observed responses;Feldman;Expert Rev Clin Immunol,2011
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Rituximab treatment for refractory and moderate-to-severe pemphigus patients in the pandemic era: A single-center retrospective study;Dermatologica Sinica;2024-01
2. A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy;Experimental Dermatology;2023-05-07
3. Pemphigus for the Inpatient Dermatologist;Current Dermatology Reports;2022-09-02
4. Therapeutic approaches and targets for treatment of autoimmune bullous diseases;Dermatologic Therapy;2021-07-14
5. Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus;Journal of Dermatological Treatment;2021-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3